STOCK TITAN

Alphatec Holdings, Inc. - ATEC STOCK NEWS

Welcome to our dedicated page for Alphatec Holdings news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Holdings stock.

Alphatec Holdings, Inc. (ATEC) is a leading medical technology company specializing in innovative spine surgery solutions. Our primary focus is the design, development, launch, and delivery of spinal fusion products aimed at improving patient outcomes. By collaborating with spine surgeons, we create and develop products and systems that address the entire spinal fusion procedure, enhancing efficiency and effectiveness.

At Alphatec Spine, we are committed to driving growth through constant innovation. Our product portfolio includes advanced technologies such as Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion. Each of these solutions is designed to simplify surgical procedures for surgeons, ultimately leading to superior patient outcomes.

We pride ourselves on our relentless pursuit of superior outcomes. By continuously developing technologies that positively impact patient care, we strive to be at the forefront of the medical technology industry. Our mission is to improve lives by providing cutting-edge spine surgery solutions.

For more detailed information about our products and ongoing projects, please visit our website at www.alphatecspine.com.

Latest News:

  • --- Source: Alphatec Holdings, Inc.
  • ---
  • ---
  • Source: Spineology Inc.
  • ---
  • ---
Rhea-AI Summary

Alphatec Holdings, Inc. (NASDAQ: ATEC) has announced its participation in three upcoming investor conferences. Pat Miles, CEO, and Todd Koning, CFO, will present at the following events:

  • The 11th Annual SVB Leerink Global Healthcare Conference: February 17, 2022, at 4:20 pm ET
  • The 42nd Annual Cowen Healthcare Conference: March 7, 2022, at 2:50 pm ET
  • The 17th Annual Canaccord Genuity Musculoskeletal Conference: March 22, 2022, at 1:00 pm CT

Webcasts will be available on the company's Investor Relations Section.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.51%
Tags
conferences
-
Rhea-AI Summary

Alphatec Holdings, Inc. (NASDAQ: ATEC) will announce its fourth quarter and full year 2021 financial results on March 1, 2022, after market close. A live webcast is scheduled for 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the webcast through the Investor Relations Section of ATEC’s website. A replay will be available for twelve months post-event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.66%
Tags
conferences earnings
-
Rhea-AI Summary

Alphatec Holdings, Inc. (NASDAQ: ATEC) announced impressive preliminary revenue results for Q4 and full-year 2021, reflecting a 41-42% U.S. organic revenue growth in Q4 and an annual growth of 50-51%. The total revenue for 2021 is expected between $242.5M to $243.3M. For 2022, ATEC anticipates a 26% growth, targeting approximately $305M in total revenue. Highlights include strong uptake of the PTP™ approach and innovative offerings, driving clinical distinction and market expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.83%
Tags
none
Rhea-AI Summary

Alphatec Holdings, Inc. (Nasdaq: ATEC) will present at the 24th Annual Virtual Needham Growth Conference on January 14, 2022, at 1:15 PM ET. The presentation will be made by Pat Miles, Chairman and CEO, and Todd Koning, CFO. A live webcast will be available on the Company’s website, with a replay accessible for 90 days thereafter. ATEC focuses on innovative spine surgery solutions through its subsidiaries, seeking to revolutionize the approach to spine surgery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
conferences
-
Rhea-AI Summary

Alphatec Holdings, Inc. (Nasdaq: ATEC) reported a significant total revenue growth of 53% for Q3 2021, with organic growth at 29%. The company's total revenue reached $62.9 million, and EOS imaging contributed over $11 million. Operating expenses were $74.7 million leading to a GAAP operating loss of $35.1 million. Looking ahead, ATEC anticipates total revenue for 2021 to be around $235 million, marking approximately 62% growth year-over-year. The adoption of the PTP Technique and enhanced product offerings are driving these results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
-
Rhea-AI Summary

Alphatec Holdings, Inc. (Nasdaq: ATEC) announced today its participation in several upcoming investor conferences. Pat Miles, Chairman and CEO, and Todd Koning, CFO, will represent the company at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021, the Stifel Healthcare Conference on November 16, 2021, and the Piper Sandler Conference from November 22 to December 2, 2021. They will also partake in the Stifel Medtech Madness Annual West Coast Bus Tour on December 13, 2021. Webcast replays will be available for 90 days post-conference.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.43%
Tags
conferences
Rhea-AI Summary

Alphatec Holdings, Inc. (NASDAQ: ATEC) announced it will release its third quarter 2021 financial results on November 4, 2021, after market close. A live webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET. Interested participants can access the webcast via ATEC's Investor Relations website. The results and insights from the call will be available for replay until November 11, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
conferences earnings
-
Rhea-AI Summary

Alphatec Holdings (NASDAQ: ATEC) has launched the InVictus OsseoScrew Expandable Spinal Fixation System, a state-of-the-art solution designed to enhance spinal fixation in patients with compromised bone quality. This system achieves a 29% increase in pull-out strength compared to conventional screws. Clinical studies indicate that it provides comparable fusion and stability outcomes while mitigating risks associated with cement leakage. The InVictus platform aims to address unmet clinical needs in spine surgery, ensuring safer and more effective patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
none
-
News
Rhea-AI Summary

Alphatec Holdings, Inc. (NASDAQ: ATEC) provided an update on its business amidst the COVID-19 pandemic, which has affected surgical volumes in the spine sector during Q3 2021. Despite lower than expected overall procedure volumes, ATEC anticipates over 25% year-over-year spine revenue growth for the quarter, although revenue will decline sequentially from Q2. The company continues to integrate EOS imaging technology and remains focused on advancing spine surgery innovation. ATEC plans to showcase its solutions at the upcoming NASS 2021 meeting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.56%
Tags
none
Rhea-AI Summary

Alphatec Holdings, Inc. (NASDAQ: ATEC) announced participation in the North American Spine Society's Annual Meeting from September 29 to October 1, 2021. The event will highlight the company’s innovative spine solutions, including the Prone TransPsoas (PTP) technique and EOS imaging technology. ATEC aims to demonstrate the clinical utility of these advancements through presentations by leading spine surgeons at booth #2308. CEO Pat Miles emphasized ATEC's commitment to revolutionizing spine surgery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
none

FAQ

What is the current stock price of Alphatec Holdings (ATEC)?

The current stock price of Alphatec Holdings (ATEC) is $9.35 as of December 20, 2024.

What is the market cap of Alphatec Holdings (ATEC)?

The market cap of Alphatec Holdings (ATEC) is approximately 1.3B.

What does Alphatec Holdings, Inc. specialize in?

Alphatec Holdings, Inc. specializes in the design, development, and delivery of innovative spine surgery solutions aimed at improving patient outcomes.

What are some of the key technologies developed by Alphatec Spine?

Key technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion.

How does Alphatec Holdings, Inc. improve spine surgery procedures?

Alphatec collaborates with spine surgeons to create products that simplify spinal fusion procedures, making them more effective and efficient.

What is the mission of Alphatec Holdings, Inc.?

The mission is to improve lives by providing innovative spine surgery solutions through relentless pursuit of superior outcomes.

How does Alphatec Holdings, Inc. drive growth?

Alphatec drives growth through continuous innovation and development of technologies that positively impact patient care.

Where can I find more information about Alphatec Holdings, Inc.?

More information can be found on their website: www.alphatecspine.com.

What recent achievements has Alphatec Holdings, Inc. made?

For the latest achievements and developments, please refer to the news section on their website or check financial news sources.

What are the main products of Alphatec Holdings, Inc.?

The main products include various spine surgery technologies such as Posterior Cervical Fusion and Lateral Interbody Fusion.

How does Alphatec Holdings, Inc. ensure superior patient outcomes?

By developing innovative technologies and working closely with spine surgeons to improve surgical procedures.

Is Alphatec Holdings, Inc. involved in any partnerships?

Yes, Alphatec collaborates with spine surgeons and other stakeholders to enhance their product offerings and improve surgical outcomes.

Alphatec Holdings, Inc.

Nasdaq:ATEC

ATEC Rankings

ATEC Stock Data

1.27B
105.57M
25.47%
57.93%
7.47%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
CARLSBAD